Trial site
Rainier Clinical Research Center
Renton, Washington 98057, United StatesNot linked to an institution yet
- 15running trials
- 20closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Phase
- Phase 314 trials
- Phase 211 trials
- Phase 11 trial
- Status
- Completed18 trials
- Active, not recruiting9 trials
- Recruiting6 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company15 trials
- Medtronic MiniMed, Inc.6 trials
- Boehringer Ingelheim3 trials
- Op-T LLC2 trials
- Tandem Diabetes Care, Inc.2 trials
- and 7 more
Running trials
Recruiting
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
NCT07864168· Medtronic MiniMed, Inc.· Source
Contact: Taylor Smith
Active, not recruiting
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
NCT07662122· Phase 2· Boehringer Ingelheim· Source
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
NCT07641517· Phase 2· Eli Lilly and Company· Source
Contact: Sheryl Marks (principal investigator)
Active, not recruiting
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
NCT07477704· Phase 2· Regeneron Pharmaceuticals· Source
Recruiting
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
NCT06964087· Phase 2· Op-T LLC· Source
Contact: Lisa Boswell
Recruiting
ROME GS System Study
NCT07518004· Senseonics, Inc.· Source
Contact: Tina Mitchell
Active, not recruiting
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
NCT07228117· Medtronic MiniMed, Inc.· Source
Active, not recruiting
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
NCT07215559· Phase 2· Eli Lilly and Company· Source
Recruiting
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
NCT07136012· Phase 3· Amgen· Source
Active, not recruiting
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
NCT06914895· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
NCT06653153· Phase 3· Eli Lilly and Company· Source
Active, not recruiting
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
NCT06643728· Phase 2· Eli Lilly and Company· Source
Active, not recruiting
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
NCT06577090· Phase 2· Skye Bioscience, Inc.· Source
Active, not recruiting
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
NCT05556512· Phase 3· Eli Lilly and Company· Source
Recruiting
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
NCT05986292· Phase 2· Eli Lilly and Company· Source
Contact: Sheryl Marks (principal investigator)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Withdrawn
SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes
NCT06719531· Medtronic MiniMed, Inc.· Source
Completed
Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes
NCT06273124· Tandem Diabetes Care, Inc.· Source
Completed
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
NCT06066528· Phase 3· Boehringer Ingelheim· Source
Completed
A Study of CT-868 in Type 1 Diabetes Mellitus
NCT06062069· Phase 2· Carmot Therapeutics, Inc.· Source
Completed
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
NCT06066515· Phase 3· Boehringer Ingelheim· Source
Completed
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
NCT06074562· Phase 2· Eli Lilly and Company· Source
Completed
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
NCT06045221· Phase 3· Eli Lilly and Company· Source
Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
NCT05929066· Phase 3· Eli Lilly and Company· Source
Completed
A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes
NCT05785832· Tandem Diabetes Care, Inc.· Source
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
NCT05882045· Phase 3· Eli Lilly and Company· Source
Completed
Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism
NCT05823012· Phase 2· Xeris Pharmaceuticals· Source
Completed
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM
NCT05714059· Medtronic MiniMed, Inc.· Source
Completed
OPT101 in Type 1 Diabetes Patients
NCT05428943· Phase 1· Op-T LLC· Source
Completed
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
NCT05463744· Phase 3· Eli Lilly and Company· Source
Completed
A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
NCT05462756· Phase 3· Eli Lilly and Company· Source
Completed
Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea
NCT05412004· Phase 3· Eli Lilly and Company· Source
Completed
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®
NCT05224258· Medtronic MiniMed, Inc.· Source
Completed
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin
NCT05275400· Phase 3· Eli Lilly and Company· Source
Completed
In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes
NCT05238142· Medtronic MiniMed, Inc.· Source
Terminated
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
NCT05085366· Phase 3· ModernaTX, Inc.· Source
Report an error